Please login to the form below

Not currently logged in

Astellas promotes John Demaree

He becomes vice president of oncology marketing, Americas

Astellas John DemareeAstellas has appointed John Demaree as vice president of oncology marketing for its Americas operations.

In his new role, Demaree will lead the promotion of in-market products, the preparation of product launches and will collaborate with Astellas' partner organisations in the region on marketing strategy.

Demaree was promoted from his position as executive director of oncology marketing, where he oversaw the launch of prostate cancer drug Xtandi (enzalutamide) and promotion of lung cancer therapy Tarceva (erlotinib).

Prior to joining Astellas in 2011, Demaree served as the general manager for oncology business development and alliance management at Abbott, and also brings experience from Eli Lilly and Novartis.

Mark Reisenauer, senior vice president of the oncology business unit for Astellas Americas, said: “Astellas is committed to making a difference in the lives of cancer patients through an emphasis on innovation and R&D.

“We are confident that John's commercial experience in oncology will help us make strides in improving care for the patients we serve.”

22nd July 2016

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company
Lucid Group Communications Limited

We are industry-leading thinkers when it comes to education. We use the latest academic thinking on the psychology of behaviour...

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...